Form 8-K - Current report:
SEC Accession No. 0001628280-17-002647
Filing Date
2017-03-16
Accepted
2017-03-16 17:03:55
Documents
1
Period of Report
2017-03-16
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 8-K - CHANGE OF AUDITORS a8kchangeofauditors.htm 8-K 27327
  Complete submission text file 0001628280-17-002647.txt   28363
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 17695326
SIC: 2834 Pharmaceutical Preparations